Citations for
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, Crary SM, Choi J, Sebastiano V, Cherry A, Giri N, Wernig M, Alter BP, Cech TR, Savage SA, Reijo Pera RA, Artandi SE.
Nature 474(7351):399-402. doi: 10.1038/nature10084. 2011
WRAP53 promotes cancer cell survival and is a potential target for cancer therapy.
Mahmoudi S, Henriksson S, Farnebo L, Roberg K, Farnebo M.
Cell Death Dis 2:e114. 2011
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita.
Zhong F, Savage SA, Shkreli M, Giri N, Jessop L, Myers T, Chen R, Alter BP, Artandi SE.
Genes Dev 25(1):11-6. 2011
WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies.
Mahmoudi S, Henriksson S, Weibrecht I, Smith S, Söderberg O, Strömblad S, Wiman KG, Farnebo M.
PLoS Biol 8(11):e1000521. 2010
5TP53, WRAP53
Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage.
Mahmoudi S, Henriksson S, Corcoran M, Méndez-Vidal C, Wiman KG, Farnebo M.
Mol Cell 33(4):462-71. 2009
6TP53, WRAP53
A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.
Venteicher AS, Abreu EB, Meng Z, McCann KE, Terns RM, Veenstra TD, Terns MP, Artandi SE.
Science 323(5914):644-8. 2009
7TP53, WRAP53
Wrap53, a novel regulator of p53.
Farnebo M.
Cell Cycle 8(15):2343-6. Epub 2009 Aug 8. 2009